Both in Pharmaceuticals
Soligenix vs Lexaria Bioscience
Over the past year SNGX returned −76.0% and LEXX returned −76.9%; their daily moves had a correlation of 0.02.
SNGX −76.0% LEXX −76.9%Growth of $1, one year, split-adjusted
| Metric | SNGX | LEXX |
|---|---|---|
| Price | $0.3751 | $3.30 |
| Market cap | $8.2M | $7.0M |
| Today | +3.33% | +2.48% |
| 1 month | +2.8% | +5.4% |
| 6 months | +11.0% | −68.1% |
| Year to date | −72.0% | −64.3% |
| 1 year | −76.0% | −78.0% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 35.8× |
| Net cash | $9.8M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 41.4% | 192.0% |
| Short % of float | 0.8% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).